Evertt Laboratories Acquires Quinnova Pharmaceuticals
Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.
Everett Laboratories, a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquarted in Madrid, Spain, has acquired Quinnova Pharmaceuticals, from parent company Amneal Enterprises.
The acquisition will result in the strategic expansion of Everett into the US dermatology market.
Summary: Everett Laboratories
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
